Search - tctmd.com

Displaying 21 - 40 of 85

Sort: Relevancy | Date

Pro vs. Con, Asymptomatic Carotid Disease: Revascularization Is Indicated – But When, Why, and How?

Presentation TCT 2023

Pro vs. Con, Asymptomatic Carotid Disease: Revascularization Is Indicated – But When, Why, and How?

Presenter: Lawrence Garcia

October 26, 2023

Pro vs Con, Asymptomatic Carotid Disease: Medical Management Is Standard of Care

Presentation TCT 2023

Pro vs Con, Asymptomatic Carotid Disease: Medical Management Is Standard of Care

Presenter: Christopher Metzger

October 26, 2023

CMS Issues Proposed Coverage Decision to Broaden Access for Carotid Stenting

News Daily News

CMS Issues Proposed Coverage Decision to Broaden Access for Carotid Stenting

July 12, 2023

Good Real-World Outcomes Seen With Next-Generation Carotid Stent

News Conference News LINC 2023

Good Real-World Outcomes Seen With Next-Generation Carotid Stent

June 06, 2023

Ticagrelor May Be an Option for Averting Brain Lesions During Carotid Stenting

News Conference News ESOC 2023

Ticagrelor May Be an Option for Averting Brain Lesions During Carotid Stenting

June 02, 2023

ECST-2: No Benefit of Carotid Revascularization on Top of Best Medical Therapy

News Conference News ESOC 2023

ECST-2: No Benefit of Carotid Revascularization on Top of Best Medical Therapy

May 26, 2023

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

News Conference News VIVA 2022

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

November 04, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

TCTMD’s Top 10 Most Popular Stories for November 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for November 2021

November 30, 2021

ACST-2: Carotid Stenting, Surgery Provide Similar Outcomes in Asymptomatic Patients

News Conference News ESC 2021

ACST-2: Carotid Stenting, Surgery Provide Similar Outcomes in Asymptomatic Patients

August 29, 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

News Opinion Editor's Corner ESC 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

August 19, 2021

PAD Continues to Elude Clinicians, Despite Gains: AHA

News Daily News

PAD Continues to Elude Clinicians, Despite Gains: AHA

August 05, 2021

Adjustable Stent Retriever Performs Well in IDE Trial

News Conference News ISC 2021

Adjustable Stent Retriever Performs Well in IDE Trial

March 24, 2021

Don’t Screen Broadly for Asymptomatic Carotid Stenosis, USPSTF Reaffirms

News Daily News

Don’t Screen Broadly for Asymptomatic Carotid Stenosis, USPSTF Reaffirms

February 02, 2021

More Insights Into AAA Genetics Spur New Questions on Screening

News Daily News

More Insights Into AAA Genetics Spur New Questions on Screening

September 29, 2020

Strokes Impacted as COVID-19 Hit the Northeastern US

News Daily News

Strokes Impacted as COVID-19 Hit the Northeastern US

August 10, 2020

Carotid Endarterectomy Little Help in Asymptomatic Patients: VA Study

News Daily News

Carotid Endarterectomy Little Help in Asymptomatic Patients: VA Study

June 04, 2020

‘Relatively Low’ Stroke Incidence in COVID-19, but More Are Cryptogenic

News Daily News

‘Relatively Low’ Stroke Incidence in COVID-19, but More Are Cryptogenic

Yael L. Maxwell

May 25, 2020

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery

News Conference News ACC 2020

PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery

Yael L. Maxwell

March 31, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.